Beth Israel Deaconess Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Beth Israel Deaconess Medical Center sits in the top decile of US sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count).
Beth Israel Deaconess Medical Center: 488 sponsored US clinical trials, 66 recruiting.
Beth Israel Deaconess Medical Center sponsors 488 registered US clinical trials on ClinicalTrials.gov, 66 of them currently recruiting, and 321 completed. 45 of these trials are in Phase 3-4 (later-stage) and 144 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 8 trials.
Top-decile sponsor footprint
Beth Israel Deaconess Medical Center ranks in the top decile of sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
321 of 380 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
488 total, page 8 of 10
Thiamine as a Metabolic Resuscitator in Septic Shock
NCT01070810
Trichuris Suis Ova in Peanut and Tree Nut Allergy
NCT01070498
IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
NCT01288963
Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)
NCT01504945
Tissue Oxygenation Measurements With Modulated Light (S-FLARE)
NCT01116297
Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment
NCT01605448
Immunomodulatory Properties of Ketamine in Sepsis
NCT01089361
Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery
NCT01149616
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
NCT00622401
The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
NCT01165983
Progressive Resistance Training in Patients With Class III Obesity
NCT01100450
Effect of Supplemental Oxygen on Maximal Oxygen Consumption in Patients With Chronic Obstructive Pulmonary Disease
NCT01294033
Regulation of FGF21 by Nutritional Challenges
NCT00968747
Exercise Program in Women With Metabolic Syndrome
NCT00929500
Evaluation of StatNet Device for Electroencephalogram (EEG) Recordings
NCT03103425
Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids
NCT01624727
Objective Flap Assessment During Reconstructive Surgery
NCT00952107
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
NCT00813293
The Effects of DHA on Periodontitis
NCT01976806
Electronic Medical Record Reminders and Panel Management to Improve Primary Care of Elderly Patients
NCT01313169
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles
NCT00908960
Self-guided Depression Treatment on Long-duration Spaceflights: A Continuation Study
NCT00906581
Serum Markers in Gluten Challenge
NCT00931892
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
NCT00782275
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
NCT00827359
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer
NCT00866723
Utility Analysis of an Endoscopy Follow-up System
NCT01172080
Physical Health in Midlife: Influences of Adversity and Relationships Over Time
NCT01853332
Near Infrared Spectroscopy (St02)
NCT01062685
Alcohol and Atherosclerosis Pilot Study
NCT00786279
The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
NCT00719134
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
NCT00749320
Leptin in the Maintenance of Reduced Body Weight
NCT01155180
Matrix Biology of Tracheobronchomalacia and Tracheal Stenosis
NCT00705848
Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage
NCT00598572
Gas Embolism With Use of Argon Plasma Coagulation
NCT00676858
Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer
NCT00721370
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
NCT00697684
Premenstrual Dysphoric Disorder and Antiepileptic Drugs
NCT00612235
Endothelium in Severe Sepsis
NCT00793442
Effects of Dietary Manipulation on Metabolism in Healthy Adults
NCT00476125
In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer
NCT00631072
Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia
NCT00903266
Statin Therapy in the Treatment of Sepsis
NCT00676897
Cerebellar rTMS for the Treatment of Schizophrenic Patients
NCT01072617
N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
NCT00780962
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
NCT00676585
Effect of Low Tidal Volume Ventilation in Improving Oxygenation and Thus Reducing Acute Lung Injury in the Cardiac Surgical Patient
NCT00538161
Outcomes of a Deep Inferior Epigastric Perforator Flap Program
NCT00543907
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 53 |
| Phase 2 | 91 |
| Phase 3 | 13 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Beth Israel Deaconess Medical Center pipeline
66 recruiting of 488 indexed (14% open); 321 completed (66%).
Phase mix: 45 late (III/IV) vs 144 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Beth Israel Deaconess Medical Center: open-pipeline peers nationwide
Peers matched on 488 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Beth Israel Deaconess Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 488 trials (± recruiting share)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 490 trials · 10% recruiting
- Fred Hutchinson Cancer Center · 483 trials · 12% recruiting
- National Heart, Lung, and Blood Institute (NHLBI) · 501 trials · 12% recruiting
- H. Lee Moffitt Cancer Center and Research Institute · 502 trials · 16% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Wayne State University · 13% recruiting · 163 trials
- University of Michigan · 13% recruiting · 1,327 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Beth Israel Deaconess Medical Center page
488 registered trials is a research-attention snapshot, not an endorsement of Beth Israel Deaconess Medical Center or any single study.
- 66 of Beth Israel Deaconess Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Beth Israel Deaconess Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Beth Israel Deaconess Medical Center pipeline card: 488 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.